Q80W65 (PCSK9_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 99.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Proprotein convertase subtilisin/kexin type 9 EC=3.4.21.- Alternative name(s): Neural apoptosis-regulated convertase 1 Short name=NARC-1 Proprotein convertase 9 Short name=PC9 Subtilisin/kexin-like protease PC9 | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 694 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments. Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation. Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway. Inhibits epithelial Na+ channel (ENaC)-mediated Na+ absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways. Ref.9 Ref.10 |
| Cofactor | Calcium Probable. |
| Enzyme regulation | Its proteolytic activity is autoinhibited by the non-covalent binding of the propeptide to the catalytic domain. Inhibited by EGTA. |
| Subunit structure | Monomer. Can self-associate to form dimers and higher multimers which may have increased LDLR degrading activity. The precursor protein but not the mature protein may form multimers. Interacts with APOB, VLDLR, LRP8/APOER2 and BACE1. The full length immature form (pro-PCSK9) interacts with SCNN1A, SCNN1B and SCNN1G. The pro-PCSK9 form (via C-terminal domain) interacts with LDLR By similarity. |
| Subcellular location | Cytoplasm By similarity. Secreted. Endosome By similarity. Lysosome By similarity. Cell surface By similarity. Endoplasmic reticulum By similarity. Golgi apparatus By similarity. Note: Autocatalytic cleavage is required to transport it from the endoplasmic reticulum to the Golgi apparatus and for the secretion of the mature protein. Localizes to the endoplasmic reticulum in the absence of LDLR and co-localizes to the cell surface and to the endosomes/lysosomes in the presence of LDLR. The sorting to the cell surface and endosomes is required in order to fully promote LDLR degradation By similarity. |
| Tissue specificity | Hepatocytes, kidney mesenchymal cells, intestinal ileum, colon epithelia and embryonic brain telencephalon neurons. |
| Developmental stage | In the embryo, expressed in the liver at day E9, in the skin and transiently in the telencephalon at day E12, and in the kidney, small intestine and cerebellum at E15. |
| Induction | Down-regulated following a high-cholesterol diet. Ref.2 |
| Domain | The C-terminal domain (CRD) is essential for the LDLR-binding and degrading activities By similarity. The catalytic domain is responsible for mediating its self-association By similarity. |
| Post-translational modification | Cleavage by furin and PCSK5 generates a truncated inactive protein that is unable to induce LDLR degradation By similarity. Undergoes autocatalytic cleavage in the endoplasmic reticulum to release the propeptide from the N-terminus and the cleavage of the propeptide is strictly required for its maturation and activation. The cleaved propeptide however remains associated with the catalytic domain through non-covalent interactions, preventing potential substrates from accessing its active site. As a result, it is secreted from cells as a propeptide-containing, enzymatically inactive protein By similarity. Ref.6 Ref.7 Phosphorylation protects the propeptide against proteolysis By similarity. |
| Sequence similarities | Belongs to the peptidase S8 family. Contains 1 peptidase S8 domain. |
| Sequence caution | The sequence AAP31672.1 differs from that shown. Reason: Erroneous initiation. The sequence BAE28934.1 differs from that shown. Reason: Erroneous initiation. The sequence CAC60362.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 34 | 34 | Potential | ||||||||
| Propeptide | 35 – 155 | 121 | PRO_0000027122 | ||||||||
| Chain | 156 – 694 | 539 | Proprotein convertase subtilisin/kexin type 9 | PRO_0000027123 | |||||||
Regions | |||||||||||
| Domain | 166 – 432 | 267 | Peptidase S8 | ||||||||
| Region | 156 – 452 | 297 | Catalytic domain By similarity | ||||||||
| Region | 453 – 694 | 242 | C-terminal domain By similarity | ||||||||
| Motif | 499 – 501 | 3 | Cell attachment site Potential | ||||||||
Sites | |||||||||||
| Active site | 189 | 1 | Charge relay system By similarity | ||||||||
| Active site | 229 | 1 | Charge relay system By similarity | ||||||||
| Active site | 389 | 1 | Charge relay system By similarity | ||||||||
| Site | 155 – 156 | 2 | Cleavage; by autolysis By similarity | ||||||||
| Site | 221 – 222 | 2 | Cleavage; by furin and PCSK5 By similarity | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 41 | 1 | Sulfotyrosine By similarity | ||||||||
| Modified residue | 50 | 1 | Phosphoserine Ref.8 | ||||||||
| Modified residue | 691 | 1 | Phosphoserine By similarity | ||||||||
| Glycosylation | 536 | 1 | N-linked (GlcNAc...) By similarity | ||||||||
| Disulfide bond | 226 ↔ 258 | Potential | |||||||||
| Disulfide bond | 326 ↔ 361 | Potential | |||||||||
| Disulfide bond | 460 ↔ 530 | Potential | |||||||||
| Disulfide bond | 480 ↔ 529 | Potential | |||||||||
| Disulfide bond | 489 ↔ 512 | Potential | |||||||||
| Disulfide bond | 537 ↔ 604 | Potential | |||||||||
| Disulfide bond | 555 ↔ 603 | Potential | |||||||||
| Disulfide bond | 565 ↔ 591 | Potential | |||||||||
| Disulfide bond | 611 ↔ 682 | Potential | |||||||||
| Disulfide bond | 629 ↔ 681 | Potential | |||||||||
| Disulfide bond | 638 ↔ 657 | Potential | |||||||||
Experimental info | |||||||||||
| Sequence conflict | 17 – 19 | 3 | Missing in CAC60362. Ref.1 | ||||||||
| Sequence conflict | 34 | 1 | A → T in CAC60362. Ref.1 | ||||||||
| Sequence conflict | 189 | 1 | D → G in CAC60362. Ref.1 | ||||||||
| Sequence conflict | 196 | 1 | H → Y in CAC60362. Ref.1 | ||||||||
| Sequence conflict | 200 | 1 | E → A in CAC60362. Ref.1 | ||||||||
| Sequence conflict | 305 | 1 | R → Q in CAC60362. Ref.1 | ||||||||
| Sequence conflict | 534 | 1 | R → H in CAC60362. Ref.1 | ||||||||
| Sequence conflict | 626 | 1 | T → A in CAC60362. Ref.1 | ||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Narc-1, novel subtilase-like homologs." Chiang L.W. Patent number WO0157081, 09-AUG-2001 Cited for: NUCLEOTIDE SEQUENCE. |
| [2] | "Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice." Maxwell K.N., Soccio R.E., Duncan E.M., Sehayek E., Breslow J.L. J. Lipid Res. 44:2109-2119(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], INDUCTION. Strain: C57BL/6. Tissue: Liver. |
| [3] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: C57BL/6J. Tissue: Liver. |
| [4] | "Lineage-specific biology revealed by a finished genome assembly of the mouse." Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S. Ponting C.P.PLoS Biol. 7:E1000112-E1000112(2009) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: C57BL/6J. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Strain: C57BL/6. Tissue: Eye. |
| [6] | "The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation." Seidah N.G., Benjannet S., Wickham L., Marcinkiewicz J., Jasmin S.B., Stifani S., Basak A., Prat A., Chretien M. Proc. Natl. Acad. Sci. U.S.A. 100:928-933(2003) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION OF PROPEPTIDE CLEAVAGE SITE, CHARACTERIZATION. |
| [7] | "Functional characterization of Narc 1, a novel proteinase related to proteinase K." Naureckiene S., Ma L., Sreekumar K., Purandare U., Lo C.F., Huang Y., Chiang L.W., Grenier J.M., Ozenberger B.A., Jacobsen J.S., Kennedy J.D., DiStefano P.S., Wood A., Bingham B. Arch. Biochem. Biophys. 420:55-67(2003) [PubMed] [Europe PMC] [Abstract] Cited for: AUTOCATALYTIC CLEAVAGE SITE. |
| [8] | "PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans." Dewpura T., Raymond A., Hamelin J., Seidah N.G., Mbikay M., Chretien M., Mayne J. FEBS J. 275:3480-3493(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-50, MASS SPECTROMETRY. |
| [9] | "Proprotein convertase subtilisin/kexin type 9 interacts with apolipoprotein B and prevents its intracellular degradation, irrespective of the low-density lipoprotein receptor." Sun H., Samarghandi A., Zhang N., Yao Z., Xiong M., Teng B.B. Arterioscler. Thromb. Vasc. Biol. 32:1585-1595(2012) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [10] | "PCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signaling." Kysenius K., Muggalla P., Maetlik K., Arumaee U., Huttunen H.J. Cell. Mol. Life Sci. 69:1903-1916(2012) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AX207688 Unassigned DNA. Translation: CAC60362.1. Different initiation. AY273821 mRNA. Translation: AAP31672.1. Different initiation. AK149520 mRNA. Translation: BAE28934.1. Different initiation. AL954352 Genomic DNA. Translation: CAM15751.1. BC038085 mRNA. Translation: AAH38085.1. |
| IPI | IPI00377933. |
| RefSeq | NP_705793.1. NM_153565.2. |
| UniGene | Mm.133268. |
3D structure databases | |
| ProteinModelPortal | Q80W65. |
| SMR | Q80W65. Positions 64-685. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 10090.ENSMUSP00000055757. |
Protein family/group databases | |
| MEROPS | S08.039. |
PTM databases | |
| PhosphoSite | Q80W65. |
Proteomic databases | |
| PaxDb | Q80W65. |
| PRIDE | Q80W65. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000049507; ENSMUSP00000055757; ENSMUSG00000044254. |
| GeneID | 100102. |
| KEGG | mmu:100102. |
| UCSC | uc008tyi.2. mouse. |
Organism-specific databases | |
| CTD | 255738. |
| MGI | MGI:2140260. Pcsk9. |
Phylogenomic databases | |
| eggNOG | COG1404. |
| GeneTree | ENSGT00490000043472. |
| HOGENOM | HOG000049267. |
| HOVERGEN | HBG053530. |
| InParanoid | B1AZI4. |
| KO | K13050. |
| OMA | HAPGLEC. |
| OrthoDB | EOG4SXNC0. |
Enzyme and pathway databases | |
| Reactome | REACT_115202. Signal Transduction. |
Gene expression databases | |
| Bgee | Q80W65. |
| CleanEx | MM_PCSK9. |
| Genevestigator | Q80W65. |
| GermOnline | ENSMUSG00000044254. Mus musculus. |
Family and domain databases | |
| Gene3D | 3.40.50.200. 1 hit. |
| InterPro | IPR010259. Inhibitor_I9. IPR000209. Peptidase_S8/S53_dom. IPR015500. Peptidase_S8_subtilisin-rel. IPR009020. Prot_inh_propept. [Graphical view] |
| PANTHER | PTHR10795. PTHR10795. 1 hit. |
| Pfam | PF05922. Inhibitor_I9. 1 hit. PF00082. Peptidase_S8. 1 hit. [Graphical view] |
| PRINTS | PR00723. SUBTILISIN. |
| SUPFAM | SSF52743. Pept_S8_S53. 1 hit. SSF54897. Prot_inh_propept. 1 hit. |
| PROSITE | PS00136. SUBTILASE_ASP. False negative. PS00137. SUBTILASE_HIS. False negative. PS00138. SUBTILASE_SER. False negative. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 354261. |
| SOURCE | Search... |
Entry information
| Entry name | PCSK9_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q80W65 Secondary accession number(s): B1AZI4 Q8CFT6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
